Big Pharma, with eye on Anthropic, says AI is shrinking drug discovery timelines
17 hours ago
Big Pharma reports AI cuts drug discovery timelines by up to 50%, citing concrete gains from firms like Sanofi and Novartis. As Anthropic approaches its IPO, industry leaders view AI tools as vital partners in accelerating molecule design.
